Sionna Therapeutics, Inc. financial data

Symbol
SION on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2527% %
Debt-to-equity 8% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,628,788 shares
Common Stock, Shares, Outstanding 44,463,527 shares
Common Stock, Value, Issued $44,000 USD
Weighted Average Number of Shares Outstanding, Basic 44,255,053 shares 887%
Weighted Average Number of Shares Outstanding, Diluted 44,255,053 shares 887%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $16,044,000 USD -35%
General and Administrative Expense $7,761,000 USD 128%
Operating Income (Loss) $23,805,000 USD 15%
Nonoperating Income (Expense) $3,527,000 USD 39%
Net Income (Loss) Attributable to Parent $20,278,000 USD 20%
Earnings Per Share, Basic -460 USD/shares -8013%
Earnings Per Share, Diluted -460 USD/shares -8013%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $50,831,000 USD 42%
Cash, Cash Equivalents, and Short-term Investments $325,000,000 USD
Assets, Current $252,328,000 USD
Property, Plant and Equipment, Net $2,144,000 USD
Operating Lease, Right-of-Use Asset $7,165,000 USD
Other Assets, Noncurrent $0 USD
Assets $339,270,000 USD
Employee-related Liabilities, Current $3,066,000 USD
Accrued Liabilities, Current $6,929,000 USD
Liabilities, Current $9,851,000 USD
Operating Lease, Liability, Noncurrent $7,751,000 USD
Liabilities $17,602,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $420,000 USD
Retained Earnings (Accumulated Deficit) $235,914,000 USD
Stockholders' Equity Attributable to Parent $321,668,000 USD
Liabilities and Equity $339,270,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares
Common Stock, Shares, Issued 44,463,527 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $51,793,000 USD 41%
Depreciation $100,000 USD -50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $20,041,000 USD 18%
Property, Plant and Equipment, Gross $4,114,000 USD
Operating Lease, Liability, Current $1,217,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Additional Paid in Capital $557,118,000 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $3,306,000 USD 222%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares